MULTI-BIOMARKER DISEASE ACTIVITY AND AUTOANTIBODY STATUS LEAD TO COST EFFECTIVE TAPERING ALGORITHMS IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION

Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, Figuereido C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nüsslein H, Alten R, Henes J, Krueger K, Schett G, Rech J (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Book Volume: 76

Pages Range: 159-159

Authors with CRIS profile

Melanie Hagen Department of Medicine 3 – Rheumatology and Immunology Matthias Englbrecht Lehrstuhl für Innere Medizin III Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology Bernhard Manger Professur für Rheumatologie und Klinische Immunologie Karin Manger Medizinische Fakultät Hubert Nüsslein Medizinische Fakultät Georg Schett Lehrstuhl für Innere Medizin III Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Julius-Maximilians-Universität Würzburg

Germany (DE) Praxiszentrum St. Bonifatius

Germany (DE) Asklepios Kliniken

Germany (DE) Schlosspark-Klinik

Germany (DE) Medizinische Universität Wien

Austria (AT) Universitätsklinikum Freiburg

Germany (DE) Medias Klinikum

Germany (DE) Ruprecht-Karls-Universität Heidelberg

Germany (DE) Eberhard Karls Universität Tübingen

Germany (DE)

How to cite

APA:

Hagen, M., Englbrecht, M., Haschka, J., Reiser, M., Kleyer, A., Hueber, A.,... Rech, J. (2017). MULTI-BIOMARKER DISEASE ACTIVITY AND AUTOANTIBODY STATUS LEAD TO COST EFFECTIVE TAPERING ALGORITHMS IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION. (pp. 159-159).

MLA:

Hagen, Melanie, et al. "MULTI-BIOMARKER DISEASE ACTIVITY AND AUTOANTIBODY STATUS LEAD TO COST EFFECTIVE TAPERING ALGORITHMS IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION." 2017. 159-159.

BibTeX: Download